GlassScriptPhysician profile
Todd W Gray
NPI 1447346630
$310.07
in general payments reported to CMS, 2019-2025
10 companies · $15.87 in 2025
The $15.87 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2021: $31.83 · 2022: $68.11 · 2023: $23.98 · 2024: $30.79 · 2025: $15.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $71.16 | 2019-2021 | |
| Pfizer INC. | $38.25 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $33.42 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.47 | 2019-2022 | |
| Medtronic, INC. | $30.79 | 2024 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $29.52 | 2019-2022 | |
| Shire North American Group INC | $25.60 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $23.98 | 2023 | Inpefa |
| Abbvie INC. | $15.87 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.